Skip to content

Axsome Therapeutics, Inc.

AXSM Nasdaq SEC CIK 1579428

Follow Axsome Therapeutics Weekly email: filings, results, news

News

11 stories filed under Axsome Therapeutics, grouped into ongoing threads

Q2

Thread · 4 stories

Axsome Therapeutics Q2 Earnings Review: I Just Can't See The Value Proposition

Earnings 44 d ago

Axsome Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation

Earnings 44 d ago 2 sources

Axsome Therapeutics, Inc. (AXSM) Q2 2026 Earnings Call Transcript

Earnings 45 d ago

Axsome Therapeutics shares gain 2% as strong sales growth offsets Q2 miss

Markets 45 d ago

More coverage

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

Markets 24 d ago also on AXS CNS

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Markets 26 d ago also on AMGN

Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run

Markets 32 d ago

RBC cuts Axsome Therapeutics stock price target on model updates

Markets 44 d ago

Guggenheim raises Axsome Therapeutics stock price target on sales beat

Markets 44 d ago

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Markets 45 d ago

Axsome therapeutics CEO Herriot Tabuteau sells $10.5m in shares

Markets 48 d ago 3 sources

Next results

NOV9

FY 2026 results

Monday · estimated from the filing cadence

Profile

Headquarters: NEW YORK, NY, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 11 stories clustered from the RSS aggregator